drugset
drugset / Trial / NCT00006760

Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma

NCT00006760 ↗

Phase 2 Completed 66 enrolled Children's Oncology Group National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as ifosfamide and vinorelbine, work in different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating children who have refractory or relapsed Hodgkin's lymphoma.

Timeline

Start
2001-05
Primary completion
2005-07
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ifosfamide Small molecule — Intravenous
Subject Vinorelbine Small molecule — Intravenous
Background filgrastim Protein / enzyme biologic — Subcutaneous

Indications

lymphoma